₹480.85
+1.67%NSE close, 16 Nov 2026
−21.11%
VASA DENTICITY is a small cap company, listed on NSE SME under the symbol DENTALKART. At ₹480.85 a share, the market values the whole company at ₹841 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹279 crore and a net profit of ₹10 crore, an operating margin of 3.9%. Over the last three years, sales grew 31.3% a year and net profit grew 10.4% a year.
Promoters hold 59.65% of the shares. Foreign institutions hold 7.67%, and domestic institutions, mutual funds among them, 1.93%.
Over the past year the share price has fallen 20.1%, and it is 21.4% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | 6M to Mar 2023 S | 6M to Sep 2023 | 6M to Mar 2024 | Sep 2024 | 6M to Mar 2025 | 6M to Sep 2025 | Dec 2025 | 6M to Mar 2026 |
|---|
Transcript
Link of Recording
Schedule of meet
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 65.8 | 76.8 | 95.1 | 112 | 136 | 133 | 72.2 | 145 | 83.1 | 87.1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 59.7 | 70.0 | 82.8 | 101 | 125 | 125 | 70.4 | 143 | 78.1 | 79.9 |
| Operating profit | 6.0 | 6.8 | 12.2 | 11.0 | 11.9 | 8.9 | 1.8 | 2.0 | 5.1 | 7.2 |
| Operating margin | 9.2% | 8.9% | 12.9% | 9.8% | 8.7% | 6.7% | 2.4% | 1.4% | 6.1% | 8.3% |
| Other income | 0.3 | 1.3 | 0.1 | 1.3 | 0.6 | 1.6 | 0.9 | 2.9 | 0.9 | 0.5 |
| Interest | 0.2 | 0.1 | 0.0 | 0 | 0.0 | 0 | 0.1 | 0.1 | 0.0 | 0 |
| Depreciation | 0.3 | 0.5 | 0.6 | 0.6 | 1.1 | 0.8 | 0.7 | 1.4 | 0.8 | 0.8 |
| Profit before tax | 5.8 | 7.6 | 11.8 | 11.7 | 11.5 | 9.7 | 1.9 | 3.5 | 5.2 | 7.0 |
| Tax | 1.4 | 1.4 | 3.0 | 2.9 | 3.3 | 2.4 | 0.5 | 0.9 | 1.1 | 1.8 |
| Net profit | 4.5 | 6.3 | 8.8 | 8.8 | 8.2 | 7.5 | 1.4 | 2.7 | 4.1 | 5.2 |
| EPS (₹) | 3.48 | 4.19 | 5.53 | 5.48 | 4.98 | 4.49 | 0.79 | 1.57 | 2.36 | 2.97 |
₹ crore, financial years to March.
| Line | FY23 S | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales | 123 | 172 | 249 | 279 |
| Expenses | 113 | 153 | 226 | 268 |
| Operating profit | 10.4 | 19.1 | 22.9 | 10.9 |
| Operating margin | 8.4% | 11.1% | 9.2% | 3.9% |
| Other income | 0.5 | 1.4 | 1.9 | 4.5 |
| Interest | 0.4 | 0.1 | 0.0 | 0.1 |
| Depreciation | 0.5 | 1.0 | 1.7 | 2.1 |
| Profit before tax | 10.0 | 19.4 | 23.1 | 13.2 |
| Tax | 2.4 | 4.3 | 6.2 | 3.3 |
| Net profit | 7.6 | 15.1 | 17.0 | 10.2 |
| EPS (₹) | 5.92 | 9.72 | 10.45 | 6.01 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY23 | FY24 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|---|
| From operations | 1.7 | −10.8 | −3.6 | −25.1 | −16.8 |
| From investing | −1.0 | −22.4 | −42.7 | −4.5 | 8.3 |
| From financing | −0.1 | 36.4 | 46.8 | 29.9 | 6.3 |
| Spent on fixed assets | – | – | −20.8 | −5.9 | −1.7 |
| Free cash flow | – | – | −24.4 | −31.0 | −18.4 |
Margins, returns, debt, tax and cash.
| Line | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net margin | 6.2% | 8.8% | 6.8% | 3.7% |
| Operating margin | 8.4% | 11.1% | 9.2% | 3.9% |
| Return on equity | – | – | 14.1% | 6.0% |
| Return on capital employed | – | – | 19.3% | 7.7% |
| Return on assets | – | – | 11.2% | 5.2% |
| Debt to equity | – | – | 0.00 | 0.00 |
| Interest coverage | 25.90 | 278.30 | 2,313.00 | 110.90 |
| Debt to assets | – | – | 0.00 | 0.00 |
| Current ratio | – | – | 7.57 | 8.01 |
| Quick ratio | – | – | 4.34 | 4.13 |
| Cash ratio | – | – | 0.26 | 0.23 |
| Asset turnover | – | – | 1.65 | 1.41 |
| Fixed asset turnover | – | – | 16.89 | 15.22 |
| Inventory turnover | – | – | 3.30 | 2.40 |
| Receivables turnover | – | – | 18.00 | 23.10 |
| Gross margin | – | – | 29.8% | 29.7% |
| Cash from operations to profit | 23.0% | -71.0% | -21.0% | -245.0% |
| Effective tax rate | 23.6% | 22.3% | 26.9% | 24.9% |
Appointment of Mr Vikas Agarwal, Reappointment as Chairman & Managing Director of the company w.e.f. November 06, 2026.
Appointment of Mr Vikas Agarwal, reappointment as Chairman & Managing Director of the company w.e.f. November 06, 2026.
Appointment of Mr Ravi kant Jagetiya, Reappointment as Non- Executive Independent Director of the company w.e.f. November 06, 2026.
Appointment of Mr Varun Chugh as Non- Executive Independent Director of the company w.e.f. November 06, 2026.
The financial results for the period ended September 30, 2026.
Has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
A copy Srutinizers report of Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results.
Appointment of Mr Sandeep Aggarwal as Whole Time Director of the company w.e.f. September 29, 2026.
Intimation regarding mutual cancellation of the proposed acquisition of an additional31.08% equity stake in IDS Denmed Private Limited